Dr Michael O’Neill, Inflection Biosciences' Director of R&D interviewed by Pharma Television
Dublin, Ireland, 16 August 2013 Inflection Biosciences Ltd, a private company focused on the development of targeted small molecule...
top of page
News
Press Releases
- Jun 4, 2013
Inflection Licenses Preclinical Oncology Programs from the Spanish National Cancer Research Centre
Dublin, Ireland, June 4, 2013 Inflection Biosciences Ltd, a private company focused on the development of targeted small molecule...
- Nov 21, 2012
Inflection Biosciences Selected to Present at International Investor Forum
Dublin, Ireland, November 21, 2012 Inflection Biosciences limited was selected as one of 25 Irish companies to present at the 5th...
- Nov 6, 2012
Inflection Biosciences to attend 24th Annual EORTC-NCI-AACR Symposium
Dublin, Ireland, November 6, 2012 Inflection Biosciences to attend the the 24th Annual EORTC-NCI-AACR Symposium on Molecular Targets and...
bottom of page